Oral contraceptives in the central nervous system: Basic pharmacology, methodological considerations, and current state of the field

Front Neuroendocrinol. 2023 Jan:68:101040. doi: 10.1016/j.yfrne.2022.101040. Epub 2022 Oct 13.

Abstract

Millions of women around the world use combined oral contraceptives (OCs), yet surprisingly little is known about their central nervous system (CNS) effects. This article provides a short overview of the basic pharmacology of OCs, emphasizing features that may be relevant to understanding their effects in the CNS. Historical and recent findings from studies of cognitive function, mood, and negative affect (depressive changes under OC use) are then reviewed. We also present data from an archival dataset from our own laboratory in which we explore dysphoric changes in women using four generations of contraceptive progestins. Current data in the field are consistent with a modest effect of OC use on CNS variables, but conclusions based on current findings must be made very cautiously because of multiple methodological issues in many published studies to date, and inconsistencies in the findings. Directions for future research over the next 10 years are suggested. (150 words).

Keywords: Cognition; Cognitive effects; Depression; Emotion; Ethinyl estradiol; Hormonal contraceptive; Mood; Negative affect; Oral contraceptive; Progestin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Central Nervous System
  • Contraceptives, Oral, Combined* / pharmacology
  • Female
  • Humans
  • Progestins*

Substances

  • Contraceptives, Oral, Combined
  • Progestins

Grants and funding